Scott V. Dols filed an amended beneficial ownership statement with the SEC on November 3, 2026, disclosing a 5.8% stake in PAVmed Inc., a medical device and technology company listed on NASDAQ:PAVM.

Key Highlights

  • Reporting person: Scott V. Dols, a United States citizen, filed Amendment No. 1 to a beneficial ownership statement as of September 30, 2026.
  • Total beneficial ownership: Dols reported 463,155 shares of PAVmed Inc. Common Stock, par value $0.001 per share (CUSIP 70387R502).
  • Percent of class: The 463,155 shares represent 5.8% of the outstanding Common Stock, based on 7,995,918 shares outstanding as of August 13, 2026.
  • Trust holdings: Of the 463,155 shares, 347,770 are held by a trust for which Dols serves as trustee; he is deemed to beneficially own those shares.
  • Voting and dispositive power: Dols holds sole voting power and sole dispositive power over all 463,155 shares, with zero shared voting or dispositive power.
  • Certification: Dols certified the shares "were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

Dols Discloses Amended Ownership Position in PAVmed Common Stock

According to the filing, Scott V. Dols, whose principal business address is listed as 19822 Wetherby Lane, Lutz, Florida 33549, submitted Amendment No. 1 to his beneficial ownership statement covering Common Stock of PAVmed Inc., a company headquartered at 360 Madison Avenue, 25th Floor, New York, New York 10017. PAVmed is a diversified commercial-stage medical device and technology company whose shares trade on NASDAQ under the ticker PAVM.

The filing states that Dols beneficially owns a total of 463,155 shares, of which 347,770 are held by a trust for which he serves as trustee. The remaining shares are held directly. The percentage of beneficial ownership, 5.8%, is calculated against 7,995,918 shares of Common Stock outstanding as of August 13, 2026, as reported in PAVmed's quarterly report on Form 10-Q filed on that date, according to the disclosure.

The event triggering this amended filing is dated September 30, 2026, per the statement. The reporting person certified that all 463,155 shares carry sole voting power and sole dispositive power in his hands alone, with no shared arrangements. As required under the applicable certification provision, Dols attested that the securities were not acquired and are not held with the intent of influencing or changing the control of PAVmed, other than activities solely in connection with a nomination under Section 240.14a-11.

What Was Disclosed

Scott V. Dols filed an amended beneficial ownership disclosure on November 3, 2026, reporting 463,155 shares of PAVmed Inc. Common Stock, equal to 5.8% of the class, with 347,770 of those shares held through a trust for which he is trustee.